Premium
Fe‐Doped Polyoxometalate as Acid‐Aggregated Nanoplatform for NIR‐II Photothermal‐Enhanced Chemodynamic Therapy
Author(s) -
Shi Yunhao,
Zhang Jiaojiao,
Huang Han,
Cao Changyu,
Yin Jiajia,
Xu Wenjing,
Wang Wenjun,
Song Xuejiao,
Zhang Yewei,
Dong Xiaochen
Publication year - 2020
Publication title -
advanced healthcare materials
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.288
H-Index - 90
eISSN - 2192-2659
pISSN - 2192-2640
DOI - 10.1002/adhm.202000005
Subject(s) - photothermal therapy , polyoxometalate , reactive oxygen species , glutathione , materials science , irradiation , cancer cell , biophysics , nanotechnology , chemistry , cancer , biochemistry , catalysis , medicine , physics , nuclear physics , biology , enzyme
The combination of reactive oxygen species‐involved chemodynamic therapy (CDT) and photothermal therapy (PTT) holds great promise in enhancing anticancer effects. Herein, a multifunctional Fe‐doped polyoxometalate (Fe‐POM) cluster is fabricated via a simple method. The Fe‐POM can not only be utilized as PTT agents to generate a hyperthermia effect for cancer cell killing under near‐infrared (NIR) II laser (1060 nm) irradiation, but also can be used as CDT agents to convert endogenous less‐reactive H 2 O 2 into harmful ·OH and simultaneously deplete glutathione for an amplified CDT effect. Notably, the hyperthermia induced by PTT can further enhance the CDT effect, achieving a synergistic PTT/CDT effect. Owing to the self‐assembling properties at lowered pH values, the Fe‐POM exhibits high tumor accumulation as revealed by photoacoustic imaging. More importantly, Fe‐POM enables effective destruction of tumors without inducing noticeable damage to normal tissues under 1060 nm laser irradiation. The work presents a new type of multifunctional agent with high PTT/CDT efficacy, providing promising methods for PTT‐enhanced CDT in a NIR‐II biowindow.